BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201002T130000
DTEND;TZID=America/New_York:20201002T150000
DTSTAMP:20200923T002332Z
CREATED:20200923T002332Z
LAST-MODIFIED:20200923T002332Z
UID:47176-1601643600-1601650800@globalbiodefense.com
SUMMARY:Got Masks? PPE Compliance and Fatigue in First Responder Realms
DESCRIPTION:The National Emerging Special Pathogen Training and Education Center (NETEC) will host ‘Got Masks? PPE Compliance and Fatigue in First Responder Realms‘ on 2 October 2020 as part of its virtual webinar series. \nAre personnel becoming less diligent with PPE? Is there a significant element of PPE fatigue? Do you know what the PPE requirements are when not actively providing patient care? What about PPE requirements in the office\, ambulance\, and firehouse? Join NETEC for a Town Hall meeting and discuss the importance of PPE in the First Responder Environment and learn techniques to deal with PPE fatigue and improve compliance? Submit your questions for the panel during registration and they will be answered during the Town Hall session. \nPlease register here: http://bit.ly/netec-ppe-compliance
URL:https://globalbiodefense.com/event/got-masks-ppe-compliance-and-fatigue-in-first-responder-realms/
LOCATION:
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201007T090000
DTEND;TZID=America/New_York:20201007T160000
DTSTAMP:20200922T214447Z
CREATED:20200922T214447Z
LAST-MODIFIED:20200922T214447Z
UID:47158-1602061200-1602086400@globalbiodefense.com
SUMMARY:Innovative Approaches to Improve Maternal and Child Health
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Innovative Approaches to Improve Maternal and Child Health‘ on 7 October 2020 as part of the DS-I Africa Virtual Forum series. \nMaternal and child health outcomes in Africa still lag behind the rest of the world despite prioritization as a topic of focus within the United Nations Sustainable Development Goals (SDGs). Partners from  country-level governments\, research institutions\, private sector program funding agencies and non-governmental organizations are involved in various capacities and across disciplines\, implementing activities to reduce the enormous burden of high mortality and morbidity of women and children on the African continent.  Nonetheless\, millions of women and children experience death and severe morbidity each year despite these efforts. In this session we will 1) address the gap in availability of existing databases and collective data focused on pregnancy and the peripartum period; 2) explore emerging use of linked data such as electronic medical records as a tool for conducting research\, analyzing data and creating tools for interventions; and 3) develop concrete recommendations for a strategy to utilize data science to improve maternal and child health outcomes from pre-pregnancy to pregnancy and delivery and throughout the mother and child’s life course. \nIntroductions:\nVesna Kutlesic\, US Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\, National Institutes of Health (NIH) \nDiana Bianchi\, Director of NICHD\, NIH \nNaveen Rao\, MD\, Senior Vice President & Senior Advisor to the President\, Health Initiative\, The Rockefeller Foundation \nModerator:\nDenise Russo\, NICHD\, NIH \nPanelists:\nAndre van der Kouwe\, Ph.D.\, Associate Professor in Radiology\, Harvard Medical School\, Assistant in Physics\, Massachusetts General Hospital \nLilla Zöllei\, Ph.D.\, Assistant Professor of Radiology\, Harvard Medical School \nMoses Alobo\, M.D.\, Program Manager\, Grand Challenges Africa Programme at African Academy of Sciences \nAlash’le Abimiku\, Ph.D.\, Professor in Epidemiology & Public Health\, University of Maryland School of Medicine; Executive Director\, International Research Center of Excellence at the Institute of Human Virology-Nigeria \nAmel Ghouila\, Ph.D.\, Bioinformatician\, Capacity Builder\, Pan African Bioinformatics \nTo participate in the discussion and session\, you must register for this DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/innovative-approaches-to-improve-maternal-and-child-health/
LOCATION:
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201014T090000
DTEND;TZID=America/New_York:20201014T160000
DTSTAMP:20200922T214817Z
CREATED:20200922T214735Z
LAST-MODIFIED:20200922T214817Z
UID:47160-1602666000-1602691200@globalbiodefense.com
SUMMARY:Using Data Science to Fight COVID-19
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Using Data Science to Fight COVID-19‘ on 14 October 2020 as part of the DS-I Africa Virtual Forum series. \nModerator:\nStefan Jaeger\, National Library of Medicine\, National Institutes of Health \nPanelists:\nAgnes Kiragga\, Ph.D.\, Head of Statistics and Data Management Unit and Senior Research Scientist\, Infectious Diseases Institute (IDI)\, Makerere University College of Health Sciences \nNirmal Ravi\, MD\, Ph.D. \nAli H. Mokdad\, Ph.D.\, Professor of Health Metrics Sciences\, the Institute for Health Metrics and Evaluation; Chief Strategy Officer\, Population Health at the University of Washington \nElaine Nsoesie\, Ph.D.\, Assistant Professor of Global Health\, Boston University School of Public Health \nFrank Kagoro\, Ph.D.\, Research Physician\, MORU Tropical Health Network and WorldWide Antimalarial Resistance Network \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/using-data-science-to-fight-covid-19/
LOCATION:
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201016T130000
DTEND;TZID=America/New_York:20201016T150000
DTSTAMP:20200923T001907Z
CREATED:20200923T001702Z
LAST-MODIFIED:20200923T001907Z
UID:47174-1602853200-1602860400@globalbiodefense.com
SUMMARY:Pediatric Perspectives During a Pandemic
DESCRIPTION:The National Emerging Special Pathogen Training and Education Center (NETEC) will host ‘Pediatric Perspectives During a Pandemic” on 16 October 2020 as part of its virtual webinar series. \nIn this webinar\, NETEC will describe the epidemiology of acute COVID-19\, including post-infectious manifestations and the unique aspects of caring for children during a pandemic. NETEC will also discuss the features of MIS-C and how to devise a diagnostic and acute management plan and integrate potential post-recovery complications into the development of follow-up plans for a child with MIS-C. \nRegister for the event here: http://bit.ly/netec-pediatric-pandemic
URL:https://globalbiodefense.com/event/pediatric-perspectives-during-a-pandemic/
LOCATION:
CATEGORIES:Continuing Education,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20201016T140000
DTEND;TZID=America/Los_Angeles:20201016T163000
DTSTAMP:20201006T183317Z
CREATED:20201006T183317Z
LAST-MODIFIED:20201006T183317Z
UID:47329-1602856800-1602865800@globalbiodefense.com
SUMMARY:Effects of the COVID-19 Pandemic on the Life Science Enterprise
DESCRIPTION:The National Academies’ Board on Life Sciences will host two panel sessions on October 16 on Effects of the COVID-19 Pandemic on the Life Science Enterprise and Inequities in the Life Sciences: Understanding the Issues. \nHow has the COVID-19 pandemic affected research\, education\, and workforce in the life sciences? This session will explore short and long-term consequences of the pandemic on life science research\, education and training\, career progression as a first step to examining resiliency within the life science research enterprise. \nInequities in the Life Sciences: Understanding the Issues \n2:00-3:00 PM \nHow do such factors as gender\, race\, and socioeconomic level affect educational\, research\, and career opportunities in the life sciences? This session will explore consequences associated with inequities in the life sciences\, needs for preventing societal injustices\, and opportunities for addressing those needs. \nSession moderator: Keegan Sawyer\, National Academies’ Board on Life Sciences \nPanelists: \n\nScott V. Edwards\, Harvard University\nPaul Barber\, University of California Los Angeles\nEdie M. Stringfellow\, MassBio\nPaul Turner\, Yale University\nShirley Malcom\, SEA Change\, American Association for the Advancement of Science\n\nEffects of the COVID-19 Pandemic on the Life Science Enterprise \n3:10-4:40 PM \nSession moderator: Nancy Connell\, Johns Hopkins Center for Health Security \nPanelists: \n\nSusan Singer\, Rollins College\nArielle Baker\, National Academies of Sciences\, Engineering\, and Medicine\nJan O. Korbel\, European Molecular Biology Laboratory\nErik Prentice\, 6F\nHolden Thorp\, AAAS/Science\nMarc Malandro\, Chan Zuckerberg Initiative\nMark Alexander\, 100 Black Men of America\, Inc\n\nThese sessions will be live streamed on the Board on Life Science website \nLearn more: http://bit.ly/nasemlifesciences \n 
URL:https://globalbiodefense.com/event/effects-of-the-covid-19-pandemic-on-the-life-science-enterprise/
LOCATION:
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/nasem-board-life-sciences-covid-19-pandemic-effects.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20201021T090000
DTEND;TZID=America/Los_Angeles:20201021T160000
DTSTAMP:20200922T215239Z
CREATED:20200922T215225Z
LAST-MODIFIED:20200922T215239Z
UID:47162-1603270800-1603296000@globalbiodefense.com
SUMMARY:Innovations in Health Metrics Sciences: Measuring\, Mapping\, and Monitoring Morbidity and Mortality at the Regional\, National\, and Local Levels in Africa
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Innovations in Health Metrics Sciences: Measuring\, Mapping\, and Monitoring Morbidity and Mortality at the Regional\, National\, and Local Levels in Africa‘ on 21 October 2020 as part of the DS-I Africa Virtual Forum series. \nThis session will highlight the emerging field of health metrics sciences and its role in measuring and monitoring summary measures of health in Africa to better develop and implement measures to reduce the burden of disease. Identify challenges and opportunities relevant to the DS-I Africa initiatives. Address the increasing role that health metrics is playing in informing and prioritizing systems-level health interventions and broad public health-related decision making. Discuss how health metrics and data science can inform and evaluate more effective integrated care efforts at the intersection of infectious diseases and the rapidly growing burden of chronic\, non-communicable diseases \nModerator:\nKaren Sliwa\, University of Cape Town \nPanelists:\nMayowa Ojo Owolabi\, University of Ibadan \nDebbie Bradshaw\, South African Medical Research Council \nAna Olga H Mocumbi\, Mondlane University \nAli H. Mokdad\, Institute for Health Metrics and Evaluation \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/innovations-in-health-metrics-sciences-measuring-mapping-and-monitoring-morbidity-and-mortality-at-the-regional-national-and-local-levels-in-africa/
LOCATION:
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201021T120000
DTEND;TZID=America/New_York:20201021T133000
DTSTAMP:20201006T184848Z
CREATED:20201006T184848Z
LAST-MODIFIED:20201006T184848Z
UID:47335-1603281600-1603287000@globalbiodefense.com
SUMMARY:Digital Genetic Sequences and International Data Sharing Policies
DESCRIPTION:The National Academies’ Board on Life Sciences will host a virtual panel discussion on October 21\, 2020 on Digital Genetic Sequences and International Data Sharing Policies. \n\nHow does the complex policy environment affect sharing of genetic sequence data internationally to address critical and pressing societal needs? This session will explore the implications of ongoing international discussions associated with sharing genetic sequence data. What policy frameworks govern the collection and sharing of digital sequence information around the world? What considerations are important for balancing open access and protection of genetic sequence data? \nSession moderator: Todd Kiuken\, North Carolina State University. \nPanelists: \n\nPatrick Reilly\, Department of State\nIan Watson\, Department of Health and Human Services\nDiane DiEuliis\, National Defense University\nHarris Lewin\, Earth BioGenome Project\n\nLearn more: http://bit.ly/nasem-lifesci-oct2020
URL:https://globalbiodefense.com/event/digital-genetic-sequences-and-international-data-sharing-policies/
LOCATION:
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/nasem-board-life-sciences-covid-19-pandemic-effects.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201021T134500
DTEND;TZID=America/New_York:20201021T150000
DTSTAMP:20201006T184647Z
CREATED:20201006T184252Z
LAST-MODIFIED:20201006T184647Z
UID:47333-1603287900-1603292400@globalbiodefense.com
SUMMARY:Biotechnology Innovations in the 21st Century
DESCRIPTION:The National Academies’ Board on Life Sciences will host a virtual panel discussion on October 21\, 2020 on Biotechnology Innovations in the 21st Century. \n\nHow is the convergence of the life sciences with other scientific disciplines and fields enabling new capabilities beyond medicine and agriculture? This session will explore innovations in biotechnology that leverage advances in several scientific disciplines\, enabling new applications and enhancing the bioeconomy. \nSession moderator: Clem Fortman\, Engineering Biology Research Consortium \nPanelists: \n\nKerri Dugan\, Defense Advanced Research Projects Agency\nMichelle Rozo\, Department of Defense\nTodd Anderson\, Department of Energy\nJohn Beieler\, Office of the Director of National Intelligence\nTheresa Good\, National Science Foundation\nElizabeth Strychalski\, National Institute of Standards and Technology\n\n\n\nLearn more: http://bit.ly/nasem-lifesci-oct2020
URL:https://globalbiodefense.com/event/biotechnology-innovations-in-the-21st-century/
LOCATION:
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/nasem-board-life-sciences-covid-19-pandemic-effects.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201022T100000
DTEND;TZID=America/New_York:20201022T170000
DTSTAMP:20200927T172033Z
CREATED:20200927T172033Z
LAST-MODIFIED:20200927T172033Z
UID:47197-1603360800-1603386000@globalbiodefense.com
SUMMARY:FDA Vaccines and Related Biological Products Advisory Committee Meeting
DESCRIPTION:On October 22\, 2020\, the Center for Biologics Evaluation and Research’s (CBER)\, Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session\, to discuss\, in general\, the development\, authorization and/or licensure of vaccines to prevent COVID-19. No specific application will be discussed at this meeting. \nFDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nThe meeting will include slide presentations with audio components to allow the presentation of materials in a manner that most closely resembles an in-person advisory committee meeting. \nPublic Participation Information\nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. \n\nWritten submissions may be made to the contact person on or before October 15\, 2020.\nOn October 22\, 2020\, oral presentations from the public will be scheduled between approximately 2:30 p.m. and 3:30 p.m. EST.\n\nThose individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present\, the names and addresses of proposed participants\, and an indication of the approximate time requested to make their presentation on or before October 7\, 2020. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session\, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by October 8\, 2020. \nWebcast Information\nCBER plans to provide a free of charge\, live webcast of the Vaccines and Related Biological Products Advisory Committee meeting. If there are instances where the webcast transmission is not successful; staff will work to re-establish the transmission as soon as possible. \nThe online web conference meeting will be available at:\nhttp://fda.yorkcast.com/webcast/Play/c26e83a0f77a412296949f4f43af4c981d
URL:https://globalbiodefense.com/event/fda-vaccines-and-related-biological-products-advisory-committee-meeting/
LOCATION:
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201027
DTEND;VALUE=DATE:20201028
DTSTAMP:20200927T165438Z
CREATED:20200802T163328Z
LAST-MODIFIED:20200927T165438Z
UID:47192-1603756800-1603843199@globalbiodefense.com
SUMMARY:BARDA Industry Day 2020
DESCRIPTION:The Biomedical Advanced Research and Development Authority (BARDA) will host a virtual Industry Day on October 27\, 2020 to learn about U.S. Government medical countermeasure priorities\, interact with the BARDA and HHS ASPR teams\, and network with public and private sector colleagues. \nFeatured speakers and breakout presenters will address the many ways BARDA is actively addressing the current COVID-19 pandemic crisis and forging new partnerships while remaining vigilant and prepared for any new threats that may arise. \nBARDA Industry Day 2020 will include breakout sessions\, virtual networking opportunities\, and an address by Acting BARDA Director\, Dr. Gary Disbrow. Lightning Talk sessions will be available to selected applicants\, which provide an opportunity to present their technologies to an audience of BARDA specialists\, industry partners\, and potential collaborators. \nThe conference is open to anyone in the public who wishes to attend. The content is mainly geared towards healthcare research professionals and medical countermeasure developers\, government agency staff\, pharmaceutical professionals\, and scientific researchers and academics. \nThe breakout sessions and plenary discussions will be available for viewing on the conference website after the event \nLearn more: http://bit.ly/bardaindustryday2020 \nEditor’s Update 31 Aug: The Lightning Talks application submission period is now closed. Event registration is still open.
URL:https://globalbiodefense.com/event/barda-industry-day-2020/
LOCATION:
CATEGORIES:Government Hosted,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/barda-industry-day-2020.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201027
DTEND;VALUE=DATE:20201031
DTSTAMP:20200922T181413Z
CREATED:20200922T181413Z
LAST-MODIFIED:20200922T181413Z
UID:47146-1603756800-1604102399@globalbiodefense.com
SUMMARY:NIH Program Funding and Grants Administration Virtual Seminar
DESCRIPTION:The National Institutes of Health invites you to take part in a unique opportunity to learn more about\nworking with the NIH grants process\, programs\, policies\, and staff at the 2020 NIH Virtual Seminar on Grants Administration and Program Funding 27-30 October 2020. \nThis seminar is designed for those who are new to working with the NIH grants process – administrators\, early stage investigators\, researchers\, graduate students\, etc. For those with more experience\, NIH experts provide a few sessions that are designed for participants that are more advanced and are focused on more in-depth polices and processes. \nWhat to expect?\nYou may be familiar with the NIH Regional Seminar and wondering if this is the same event moved to a virtual environment. There are some similarities\, but also some modifications to accommodate the new format. \n\nThis event is scheduled over four days in the afternoons only (U.S. New York time zone – EDT). Sessions 1:00 PM – 5:45 PM\nThere are three tracks of sessions which are open to any participants on any given day without any further registration.\nAll sessions are 45-minute sessions with a 15 minute break before the next session begins. Some are live\, while others are simulive (a combination of a pre-recorded video and live Q&A).\nRepresentatives from NIH programs\, offices\, and Institutes and Centers will be presenting and attending booths in the Meet the Experts Exhibit Hall.\nThe seminar is free!\n\nTuesday\, October 27 – Thursday\, October 29 \n\n\nTrack 1\nNIH Grant Process \n\n\nLooking for an overview of the NIH Grant Process from application preparation to post-award management? This is the track for you! \n\n\n\n\nTrack 2\nNIH Grant Policies & Programs \n\n\nWanting to learn about specific programs offered by NIH or receive updates on the latest NIH & HHS policies? Check out this track. \n\n\n\n\nTrack 3\nLet’s Talk About It \n\n\nSessions in this track are designed to be more interactive with Question & Answer sessions and case studies. \n\n\nFriday\, October 30 \nTracks are slightly different with sessions that are primarily focused on a general topic or program: \n\n\nSpecial Focus 1:\nHuman Subjects in Research \n\n\nIf your research meets the definition of involving human subjects\, then you’ll want to participate in these sessions provided by OHRP and NIH. \n\n\n\n\nSpecial Focus 2:\nSEEDing the Marketplace \n\n\nThe NIH SEED (Small business Entrepreneurial Education) team is providing a track focused on developing relationships and building relationshops for innovators to move towards production. \n\n\n\n\nTrack 3\nLet’s Talk About It \n\n\nVisit this track for sessions focused on business\, inventions\, and data. Visit for more interactive with Q&A and/or case studies. \n\n\nWho are the Presenters?\nThis seminar involves over 50 NIH and HHS presenters and over 100 additional experts at the NIH booths who are eager to educate\, share\, and hear your questions during this event. It’s your opportunity to interact with NIH policy officials\, grants management\, program and review staff\, and representatives from the HHS Office for Human Research Protections (OHRP) and HHS Office of Research Integrity. Select the “Presenters” tab to see a selection of NIH & HHS experts who will be providing presentations. \nView the full AGENDA \nRegister HERE.
URL:https://globalbiodefense.com/event/nih-program-funding-and-grants-administration-virtual-seminar/
LOCATION:
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201027T133000
DTEND;TZID=America/New_York:20201027T163000
DTSTAMP:20201023T154239Z
CREATED:20201012T153755Z
LAST-MODIFIED:20201023T154239Z
UID:47618-1603805400-1603816200@globalbiodefense.com
SUMMARY:COVID-19 and the Geography of Vulnerability
DESCRIPTION:The National Academies Geographical Sciences Committee will host a virtual keynote talk on Oct. 27 on “COVID-19 and the Geography of Vulnerability“. \nOur understanding of the geographic spread of COVID-19 has largely been based on national-scale epidemiological models\, while the place-based responses to community-level impacts of the disease have mainly been informed by local-scale surveys and reports of the lived experiences of individuals within those communities. Geographers have the capacity to integrate local and population-scale research\, yet examples of this type of integration are rare among studies of vulnerability. \nDuring this meeting\, the National Academies’ Geographical Sciences Committee will examine the geography of vulnerability in the context of the COVID-19 pandemic. This meeting will be held to discuss the following questions and consider potential next steps that could be taken to advance the capacity to characterize\, predict\, and alleviate vulnerability. \nFeaturing Keynote Talk by Dr. Eric Tate\, Associate Professor\, University of Iowa\nSocial Vulnerability and Place-based Risk \nPanelists \nDr. Elisabeth Root\, Professor\, Ohio State University: Identifying Vulnerability from the COVID-19 Data: What is Possible and What is Missing? \nDr. Peter Smittenaar\, Director of Data Science and AI\, Surgo Foundation: COVID-19 Community Vulnerability Index: Capturing the Geographical Dimensions of Vulnerability \nDr. LaToya Eaves\, Assistant Professor\, University of Tennessee: Intersectional Geographies and COVID-19 \nDr. Karen Falconer Al-Hindi\, Professor\, University of Nebraska\, Omaha \nDr. Aaron Strong\, Economist\, RAND Corporation \nPlease visit NASEM’s COVID-19 and the Geography of Vulnerability event website for more information.
URL:https://globalbiodefense.com/event/covid-19-and-the-geography-of-vulnerability/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/covid-19-georgraphy-vulnerability-nasem.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201027T190000
DTEND;TZID=America/New_York:20201027T203000
DTSTAMP:20201023T054154Z
CREATED:20201023T054028Z
LAST-MODIFIED:20201023T054154Z
UID:47604-1603825200-1603830600@globalbiodefense.com
SUMMARY:A Guided Exploration of COVID-19 and One Health
DESCRIPTION:The One Health Academy will host “A Guided Exploration of COVID-19 and One Health” presentation via webinar by Dr. Jessica Petrillo on October 27\, 2020. \nJessica Petrillo\, PhD is an expert on global health security policy working with diverse domestic and international stakeholders and partners to devise and implement strategic and innovative approaches to enable immediate and lasting change globally. Jessica serves as Senior Advisor for Antimicrobial Resistance (AMR) and GHSA as a Sustaining Technical and Analytic Resources Fellow at USAID with responsibility for strengthening the Agency’s technical capacity in and strategic approach to advance priority health security objectives. These include addressing the emergence\, spread\, and impact of AMR and strengthening global capacity to prevent\, prepare for\, respond to and recover from infectious disease threats including through USAID’s involvement in the National Biodefense Strategy (NBS) and Global Health Security Agenda (GHSA). Previously\, Jessica served as Senior Advisor for Health Security at the U.S. Department of State. She served as a lead for negotiating and implementing the NBS and GHSA and led the Department’s foreign policy work on AMR which included efforts to enhance action by faith-inspired organizations and the arts communities\, and improve the scientific and policy understanding of the environmental component AMR. \nDr. Petrillo received her PhD in Virology from Harvard University and conducted her postdoctoral research at the Scripps Research Institute. \nWebinar is free but you must Register here to receive your unique login link.
URL:https://globalbiodefense.com/event/a-guided-exploration-of-covid-19-and-one-health/
LOCATION:https://register.gotowebinar.com/register/7194478824802608908
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201028T113000
DTEND;TZID=America/New_York:20201028T133000
DTSTAMP:20201023T160807Z
CREATED:20201016T160257Z
LAST-MODIFIED:20201023T160807Z
UID:47625-1603884600-1603891800@globalbiodefense.com
SUMMARY:SEAN and Standing Committee on Emerging Infectious Diseases College COVID-19 Testing Strategies
DESCRIPTION:Participate in this virtual listening session on Oct. 28 focused on the landscape of current COVID-19 testing strategies. Participants will hear from representatives of several large and mid-sized colleges and universities. \nBACKGROUND \nAs part of its work advising the nation on responding to COVID-19\, the National Academies of Sciences\, Engineering\, and Medicine (NASEM) is holding a series of four public sessions to inform a forthcoming rapid expert consultation on testing strategies and capabilities at colleges and universities. \nEach session will include a framing of the issues and an overview of one or more of the major considerations that affect decisions about testing strategies and capabilities. \nA range of universities and colleges will share their experiences with COVID-19 testing\, further illustrating those considerations. \nA facilitated conversation will foster dialog among universities and colleges and with other subject matter experts and stakeholders. \nThe events are hosted by the Societal Experts Action Network (SEAN): Facilitating Rapid and Actionable Responses to Social\, Behavioral\, and Economic-Related COVID-19 Question. \nVisit NASEM’s event website for more information. \n 
URL:https://globalbiodefense.com/event/sean-and-standing-committee-on-emerging-infectious-diseases-college-covid-19-testing-strategies/
LOCATION:https://nas-sec.zoomgov.com/webinar/register/WN_W8iXc00YQ9uGLipUXAGQAw
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201028T113000
DTEND;TZID=America/New_York:20201028T153000
DTSTAMP:20201024T215523Z
CREATED:20201024T215523Z
LAST-MODIFIED:20201024T215523Z
UID:47656-1603884600-1603899000@globalbiodefense.com
SUMMARY:National Virtual Biotechnology Laboratory Symposium
DESCRIPTION:The National Virtual Biotechnology Laboratory Symposium will be held Oct. 28\, 2020. \nThis online event will highlight the impact the U.S. Department of Energy’s (DOE) National Virtual Biotechnology Laboratory has had utilizing the unique capabilities of the DOE to tackle the science and technology challenges associated with COVID-19\, and to discuss areas in which the National Virtual Biotechnology Laboratory can have impact in the future. \nSPEAKERS \n\nOverview of Science & Technology Challenges for COVID – NVBL Co-Leads Michelle Buchanan\, Oak Ridge National Laboratory\, and Stephen Streiffer\, Argonne National Laboratory\nFuture S&T Needs: Future of Testing & Surveillance – Bruce Tromberg\, Director\, National Institute of Biomedical Imaging & Bioengineering\, National Institutes of Health\nFuture S&T Needs: AI/ML and Computing – Jim Brase\, Deputy Associate Director for Computation\, Lawrence Livermore National Laboratory\nFuture S&T Needs: Vaccines – Greg Burel\, President\, Hamilton Grace\, LLC\nClosing Remarks – Harriet Kung\, Deputy Director for Science\, DOE Office of Science\n\nThe U.S. Department of Energy National Virtual Biotechnology Laboratory (NVBL) is a consortium of DOE National laboratories\, each with core capabilities relevant to the threats posed by COVID-19. The NVBL is taking advantage of DOE user facilities\, including light and neutron sources\, nanoscale science centers\, sequencing and bio-characterization facilities\, and high performance computer facilities\, to address key challenges in responding to the COVID-19 threat.  Examples include developing innovations in testing capabilities\, identifying new targets for medical therapeutics\, providing epidemiological and logistical support\, and addressing supply chain bottlenecks by harnessing extensive additive manufacturing capabilities.  The NVBL collaborates extensively with researchers\, both in academia and the private sector.  In addition\, the DOE user facilities are available to users in all sectors of the research community. \nRegister in advance for this webinar event.
URL:https://globalbiodefense.com/event/national-virtual-biotechnology-laboratory-symposium/
LOCATION:https://www.zoomgov.com/webinar/register/WN_1nEkc3YYR2ODU-W0ZzODlA
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201028T170000
DTEND;TZID=America/New_York:20201028T180000
DTSTAMP:20201023T161344Z
CREATED:20201023T161324Z
LAST-MODIFIED:20201023T161344Z
UID:47628-1603904400-1603908000@globalbiodefense.com
SUMMARY:Assessment of the SBIR and STTR Programs at NIH Meeting No.7
DESCRIPTION:The Seventh Meeting of the Committee on the Assessment of the SBIR and STTR Programs at the National Institutes of Health will be held virtually on Oct. 28\, 2020 5:00PM – 6:00PM ET. \nIn response to a Congressional mandate\, an ad hoc committee will conduct a study of the economic and healthcare benefits of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH) and the effectiveness of the enabling strategies NIH has employed to enhance the programs. The committee will draw on published research; existing\, available data; and case studies\, and convene a series of meetings. Specifically and to the extent that data are available\, the committee will examine: \nSBIR effectiveness: Leveraging existing NIH evaluation strategies and data that are made available to the committee\, case studies\, and other available data\, the committee will examine whether the NIH SBIR Program is fulfilling the requirements of the enabling legislation; and study the impact and effectiveness of the enabling strategies NIH has employed to enhance the program\, including\, but not limited to\, technical and business assistance programs and the Phase IIB program. \nSTTR effectiveness: Leveraging existing NIH evaluation strategies and data that are made available\, the committee will study how the NIH STTR Program\, including the strategies designed to enable academic entrepreneurship and innovation\, has fulfilled the requirements of the enabling legislation\, including: \n\nA review of the collaborations created between small businesses and research institutions\, including an evaluation of the effectiveness of the program in stimulating new collaborations and any obstacles that may prevent or inhibit the creation of such collaborations.\nAn evaluation of the effectiveness of the program at transferring federally funded technology and capabilities toward commercialization.\nAn examination of the non-economic impacts to businesses including measures of demographics\, participation of underrepresented groups\, and knowledge of the technical and business requirements of life science sector commercialization.\nAn analysis of whether STTR funds could be employed more effectively by the NIH STTR program to achieve the goals of the enabling legislation.\n\nEconomic and healthcare impact: The committee will examine the regional economic impacts associated with the NIH SBIR and STTR programs\, including relevant measures such as firm survival\, direct and indirect employment effects\, business revenues\, and gross value added; assess the contribution of the NIH SBIR and STTR programs to regional economic development programs and strategies\, including those around inclusivity and workforce development; and assess healthcare impacts of the NIH SBIR and STTR programs\, including an assessment of the relationship between technology outcomes supported by the NIH SBIR and STTR programs and commercially available healthcare products and services. \nThe committee will produce a consensus report with the committee’s findings and its recommendations for how to improve the programs.
URL:https://globalbiodefense.com/event/assessment-of-the-sbir-and-sttr-programs-at-nih/
LOCATION:
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201029T180000
DTEND;TZID=America/New_York:20201029T190000
DTSTAMP:20201023T144416Z
CREATED:20201023T034509Z
LAST-MODIFIED:20201023T144416Z
UID:47595-1603994400-1603998000@globalbiodefense.com
SUMMARY:Job Talk: Careers in Policy and Security
DESCRIPTION:Join the Schar School of Policy and Government and guest panelists to get an insight on how a Schar School degree can launch or advance your career in policy and security. Hear from industry experts on ways to research and build out a career roadmap from the scope of available opportunities. Panelists will share their knowledge on skills critical to preparing for professional success. \nPANELISTS: \nLarry Hanauer serves as the Vice President for Policy at the Intelligence and National Security Alliance (INSA)\, a non-profit\, non-partisan organization that promotes public-private partnerships within the national security and intelligence communities. \nCurt Gaucher has recruited intelligence professionals for several years for a number of firms and currently manages a team of recruiters as a Senior Manager of Talent Management and Strategy with the Intelligence and Homeland Security Division of General Dynamics Information Technology. \nKathleen Lackey is a Staff Officer with the Department of Defense and a 2018 graduate of the Schar School’s MA in International Security. She also served as a Graduate Student Fellow with the Schar School’s Center for Security Policy Studies. \nSaskia Popescu is a 2019 graduate of the Schar School’s PhD in Biodefense program and is a nationally recognized expert in hospital-based infection prevention. She also serves as a Term Assistant Professor in the Schar School’s graduate programs in biodefense. \nVisit the GMU Schar School website more information and to register for this event: http://bit.ly/gmuscharschooljobtalk
URL:https://globalbiodefense.com/event/job-talk-careers-in-policy-and-security/
LOCATION:
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/gmu-schar-school-security-policy-job-talk-graduate-programs-events-1280.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201104
DTEND;VALUE=DATE:20201107
DTSTAMP:20201023T150017Z
CREATED:20201023T150017Z
LAST-MODIFIED:20201023T150017Z
UID:47613-1604448000-1604707199@globalbiodefense.com
SUMMARY:6th African Conference on Emerging Infectious Diseases & Biosecurity
DESCRIPTION:The 6th African Conference on Emerging Infectious Diseases & Biosecurity will be held 4-6 November 2020 in Lagos\, Nigeria with virtual participation options. \nHighlighted conference topics this year contributing to the overarching theme of “Strengthening Africa’s Resilience in tackling emerging biosecurity threats: Lessons from COVID-19” include: \n\nBiosecurity and biothreat reduction in Africa\nClimate change and biosecurity threats in Africa\nInternational biosecurity conventions: Biological weapons\nHarnessing the digital revolution and digital platforms to advance biosecurity\nBiobanking infrastructure\nEmerging infectious diseases as an accelerating phenonmenon\nNeed for a vaccine strategy for the continent\nCultural\, Anthropological\, Social and Economic Impact of Emerging Infectious Diseases (CASE)\nRole of African governments and indigenous vaccine manufacturers in vaccine R&D\n\nPlease visit GET Africa’s 6th African Conference on Emerging Infectious Diseases & Biosecurity website for more information. \n 
URL:https://globalbiodefense.com/event/6th-african-conference-on-emerging-infectious-diseases-biosecurity/
LOCATION:The Civic Centre\, Ozumba Mbadiwe Road\, Opposite 1004\, Lagos\, 100001\, Nigeria
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201104T070000
DTEND;TZID=America/New_York:20201104T090000
DTSTAMP:20201101T235235Z
CREATED:20201022T224522Z
LAST-MODIFIED:20201101T235235Z
UID:47772-1604473200-1604480400@globalbiodefense.com
SUMMARY:Side Meeting at the 6th Global Health Security Agenda Ministerial Meeting
DESCRIPTION:The GHSA Consortium for the GHSA Task Force on Advocacy & Communications will host a Side Meeting at the 6th Global Health Security Agenda Ministerial Meeting on 4 November 2020. \nThis side event will highlight promising practices for meaningfully expanding partnerships across human\, animal\, agriculture\, and environmental sectors to improve health outcomes and local\, national\, and global health security. \nHighlighted topics include: \n\nIdentifying good\, better\, and best practices\nWildlife and environment: Connections to health security\nFostering multisectoral coordination in countries to effectively contain antimicrobial resistance\nCommunicating across sectors: Early warning systems and preparedness\nSustaining engagement with environment sector partners: Systems\, processes\, capacity and resources\n\nThe event will take place 0700-0900 EST (New York) and 1900-2100 local (Thailand). \nPlease register via the GHSA Ministerial website. Once registered\, the event will be broadcast from: https://www.ghsamm2020.com/streams/245 \nAbout GHSA \nThe Global Health Security Agenda (GHSA) 2024 Framework emphasizes the importance of engaging all relevant sectors to achieve sustainable and measurable results toward common targets for global health security. Changing conditions at local and global scales – related to deforestation and habitat loss\, wildlife trade\, and changing food systems and agricultural intensification with inadequate biosecurity – are shaping novel and increased interactions between species that facilitate opportunities for the spillover of disease. \nThe consequences are striking: more than 70% of emerging zoonotic diseases have origins in wildlife\, and climate-sensitive vector-borne diseases are appearing in new regions\, together causing extensive health and economic impact. The same drivers\, combined with the misuse and overuse of antibiotics\, have accelerated the emergence of antimicrobial resistance (AMR) among interconnected microbiomes in humans\, animals\, and the environment\, which can be spread across borders through trade\, travel\, and other movement of people and animals. Understanding the links between the environment and health risks and outcomes is critical to enhancing surveillance and detection\, develop early warning systems\, and target multisectoral risk reduction strategies to address known and novel threats. \n 
URL:https://globalbiodefense.com/event/side-meeting-at-the-6th-global-health-security-agenda-ministerial-meeting/
LOCATION:https://www.ghsamm2020.com/streams/245
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/11/ghsa-side-event-global-health-security-agenda.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201104T121500
DTEND;TZID=America/New_York:20201104T131500
DTSTAMP:20201103T012824Z
CREATED:20201003T002424Z
LAST-MODIFIED:20201103T012824Z
UID:47785-1604492100-1604495700@globalbiodefense.com
SUMMARY:FDA Virtual Town Hall Series - COVID-19 Test Development and Validation
DESCRIPTION:The U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for SARS-CoV-2 test developers 4 Nov 2020 from 12:15 PM – 1:15 PM Eastern. \nThe FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases\, including the Coronavirus Disease 2019 (COVID-19) pandemic. The FDA is committed to providing timely guidance to support response efforts to this pandemic. \nThe immediately in effect guidance “Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised)” includes policies specific to this public health emergency. This guidance was issued on February 29\, 2020 and subsequently updated on March 16\, 2020\, May 4\, 2020\, and May 11\, 2020. \nThe FDA will also hold virtual Town Halls for test developers to help answer questions on: \n\nNovember 18\, 2020 from 12:15 pm – 1:15 pm Eastern Time\nDecember 2\, 2020 from 12:15 pm – 1:15 pm Eastern Time\nDecember 9\, 2020 from 12:15 pm – 1:15 pm Eastern Time\nDecember 16\, 2020 from 12:15 pm – 1:15 pm Eastern Time\n\nLearn more
URL:https://globalbiodefense.com/event/fda-virtual-town-hall-series-covid-19-test-development-and-validation/
LOCATION:
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201105T120000
DTEND;TZID=America/New_York:20201105T130000
DTSTAMP:20201101T235722Z
CREATED:20201023T054551Z
LAST-MODIFIED:20201101T235722Z
UID:47610-1604577600-1604581200@globalbiodefense.com
SUMMARY:USAID: Conflict Assessment Framework
DESCRIPTION:Join HDIAC Thursday\, November 5 for a webinar presentation titled “USAID: Conflict Assessment Framework.”  \nIn order to best understand the environments where they work\, the United States Agency for International Development (USAID) uses a diagnostic tool called the Conflict Assessment Framework to analyze national and sub-national conflict. A conflict assessment is a systematic process used to analyze and prioritize the dynamics of peace\, conflict\, stability\, and instability in a given country context. The assessment consists of two stages: diagnosis and response. During the diagnosis phase\, the assessment team gathers information about the country’s internal conflict dynamics. The team then uses its findings to identify likely future scenarios that could alter a country’s risk of violent conflict. During the response stage\, the assessment team draws on its rich diagnostic analysis to formulate actionable responses. Conducting a field-based conflict assessment is challenging. It involves applying a set of rigorous analytical tasks in a dynamic process\, which must be sensitive to issues from policy positions\, organizational interests\, interpersonal and intercultural dynamics\, language\, and logistical constraints. This webinar will provide an overview of the assessment process and methods\, as well as provide illustrative examples from previously conducted field assessments.  \nPlease register in advance for the webinar.
URL:https://globalbiodefense.com/event/usaid-conflict-assessment-framework/
LOCATION:https://www.anymeeting.com/PIID=EF55D884864F3F
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201105T120000
DTEND;TZID=America/New_York:20201105T140000
DTSTAMP:20200927T193658Z
CREATED:20200927T193658Z
LAST-MODIFIED:20200927T193658Z
UID:47219-1604577600-1604584800@globalbiodefense.com
SUMMARY:Changes in Pathogen Exposure Pathways under Non-Stationary Conditions and Their Implications for Wildlife and Human Exposure on DoD Lands
DESCRIPTION:A webinar on “Changes in Pathogen Exposure Pathways under Non-Stationary Conditions and Their Implications for Wildlife and Human Exposure on Department of Defense Lands” will be presented on Nov. 5\, 2020. \nHosted by the Strategic Environmental Research and Development Program (SERDP) and Environmental Security Technology Certification Program (ESTCP)\, this seminar will be presented by Dr. Sara Olson from the Wildlife Conservation Society. \nA fungal disease called white-nose syndrome (WNS)\, originally identified in 2006 in New York state\, has killed millions of hibernating bats in North America. In advance of its spread across western North America\, this research effort involved the collection of empirical data on bat hibernation physiology to better inform our understanding of western bat WNS risk factors and priorities for possible mitigations. As part of this work\, we hypothesized that the differential mortality due to WNS observed among hibernating species was related to species-level bioenergetic traits and environmental factors. Our hypothesis was tested using empirical data and bioenergetic models. In advance of WNS arrival\, our team collected basic morphometric trait data on 3\,073 bats representing 14 species across 14 sites in Alberta\, British Columbia\, Colorado\, Montana\, Northwest Territories\, Nevada\, Oklahoma\, Oregon\, Texas and Utah. Respirometry and body composition data were collected for a subset of 580 and 464 bats\, respectively\, for analysis of 12 species. Microclimate measurements were also collected within hibernacula. The data collected as part of this effort are the first to establish valuable pre-WNS reference points for the hibernation physiology of these western bat species. The data\, analyses and modeling tools presented during this webinar will help inform DoD and other land managers who are responsible for bat management and mitigation activities by identifying specific WNS risk factors as well as susceptible and more resilient western species and populations. \nDr. Sarah Olson is the Associate Director of Epidemiology for the Wildlife Conservation Society (WCS) Health Program. Although the program is based out of the Bronx Zoo in New York\, Dr. Olsen is physically based out of Bozeman\, Montana. Her ongoing research efforts focus on assessing the risk of white-nose disease syndrome to North American hibernating bats\, tracking human health threats associated with wildlife trade in Asia\, establishing national wildlife health surveillance platforms\, and researching the disease ecology of filoviruses in Central African fruit-bats. In addition to leading scientific studies\, Dr. Olson provides research support to field veterinarians and conservation staff around the world on wildlife health threats and zoonotic diseases with a focus on promoting the understanding of conservation impact of front-line wildlife diseases\, building One Health capacity\, and translating science into effective and lasting interventions. She received bachelor’s degrees in microbiology and German from Montana State University\, and a joint doctoral degree in population health and environment from the University of Wisconsin in Madison. \nLearn more here.
URL:https://globalbiodefense.com/event/changes-in-pathogen-exposure-pathways-under-non-stationary-conditions-and-their-implications-for-wildlife-and-human-exposure-on-dod-lands/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201109
DTEND;VALUE=DATE:20201111
DTSTAMP:20201108T212120Z
CREATED:20201101T211658Z
LAST-MODIFIED:20201108T212120Z
UID:47853-1604880000-1605052799@globalbiodefense.com
SUMMARY:Aberdeen Proving Ground Virtual Career Fair
DESCRIPTION:Organizations across Aberdeen Proving Ground will accept resumes during the installation’s first virtual career fair November 9 and 10\, 2020. \nThe virtual hiring event\, hosted by the U.S. Army Communications-Electronics Command\, will provide opportunities for applicants to submit their resumes and other information through an online\, mobile recruiting application. \n“We are excited for our first ever virtual job fair for the APG community\,” said CECOM Human Resources Specialist Steve Faulkner. “COVID-19 has forced us all into being more innovative in our approach in human resources\, particularly in recruiting.” \nIn an effort to practice social distancing\, about half a dozen APG organizations and subordinate commands will use the virtual event to recruit candidates for a variety of career fields in multiple locations. For career opportunities in information technology\, law enforcement\, engineering\, financial management\, logistics\, communications\, just to name a few\, applicants will apply for positions from the safety of their personal computers and mobile devices. \nAPG – Career Fair\nAPG is relying on its social media channels to promote hiring opportunities\, and to engage potential candidates. Job seekers are encouraged to ask questions and share the event information with friends\, to ensure high visibility and maximum participation. \n“To meet the mission\, hiring organizations must continue to hire the best qualified employees\,” Faulkner said. “We have opportunities at APG; Tobyhanna\, Pennsylvania; Fort Detrick\, Maryland; Fort Huachuca\, Arizona; Fort Belvoir\, Virginia\, and many more locations.” \nSome of the participating organizations include CECOM\, the Army 20th CBRNE Command\, APG Garrison\, Army Futures Command organizations\, Army Medical Research Institute of Chemical Defense (USAMRICD)\, Army Program Executive Office – Command\, Control and Communications Tactical and many more. \nThe APG workforce has more than 21\,000 military\, civilian and contractor employees responsible for numerous technical achievements across a broad spectrum of military capabilities. If a Soldier uses a piece of technology for protection\, intelligence\, shooting\, movement or to communicate\, chances are it was developed\, tested and fielded by an APG organization. \nThe APG Virtual Career Fair event page on Facebook includes information on hiring organizations and how to submit resumes. Learn more: https://www.facebook.com/events/354326535799511
URL:https://globalbiodefense.com/event/aberdeen-proving-ground-virtual-career-fair/
LOCATION:
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/11/apg-usamricd-virtual-career-fair.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201112T183000
DTEND;TZID=America/New_York:20201112T200000
DTSTAMP:20201109T150749Z
CREATED:20201023T041149Z
LAST-MODIFIED:20201109T150749Z
UID:47599-1605205800-1605211200@globalbiodefense.com
SUMMARY:GMU Schar School Master’s and Certificate Virtual Open House
DESCRIPTION:You’re invited to attend a virtual open house to learn more about the Schar School of Policy and Government and our academic programs. The online session will provide an overview of our master’s degree programs and graduate certificate programs\, student services\, and admissions requirements. \nFormer Deputy Director of the FBI Andrew McCabe\, now a Schar School Distinguished Visiting Professor\, will also greet prospective students and share his security experience. \nPlease visit the GMU Schar School website here for more information: Master’s and Certificate Virtual Open House
URL:https://globalbiodefense.com/event/gmu-schar-school-masters-and-certificate-virtual-open-house/
LOCATION:
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/gmu-open-house-virtual-event-andrew-mccabe.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201117T120000
DTEND;TZID=America/New_York:20201117T133000
DTSTAMP:20201113T195436Z
CREATED:20201023T051656Z
LAST-MODIFIED:20201113T195436Z
UID:47602-1605614400-1605619800@globalbiodefense.com
SUMMARY:The Resurgent Chemical Weapons Threat: Current Challenges to the Chemical Weapons Convention
DESCRIPTION:The chemical weapons nonproliferation regime is at a crossroads. Chemical weapons have made a comeback with deadly nerve agents being used by Russia\, Syria\, and North Korea against perceived “enemies of the state.” Join a distinguished panel of international experts in a discussion about how to restore the taboo against the use of chemical weapons and how the organization for the Prohibition of Chemical Weapons (OPCW) can prevent the further misuse of chemistry. \nPANELISTS: \nDr. Stefano Costanzi is an Associate Professor of Chemistry at American University in Washington DC. \nDr. Malcolm Dando is a Leverhulme Trust Emeritus Fellow in the Department of Peace Studies at the University of Bradford in the UK. \nDr. Jean Pascal Zanders is an independent researcher/consultant on disarmament and security based in France. \nThe event will be moderated by Dr. Gregory D. Koblentz\, Associate Professor and Director of the Biodefense Graduate Program at the Schar School of Policy and Government at George Mason University. \nPlease visit the Schar School website for more information: The Resurgent Chemical Weapons Threat: Current Challenges to the Chemical Weapon Convention.
URL:https://globalbiodefense.com/event/the-resurgent-chemical-weapons-threat-current-challenges-to-the-chemical-weapon-convention/
LOCATION:
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/schar-school-resurgent-chemical-weapons-threat-cwc.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201117T190000
DTEND;TZID=Europe/London:20201117T203000
DTSTAMP:20201106T161357Z
CREATED:20201106T161308Z
LAST-MODIFIED:20201106T161357Z
UID:47845-1605639600-1605645000@globalbiodefense.com
SUMMARY:Toxic: A History of Nerve Agents
DESCRIPTION:The Royal Institution will host a live stream talk led by Dan Kaszeta on “A History of Nerve Agents” on Tuesday 17 November. \nNerve agents are the world’s deadliest means of chemical warfare. Kaszeta uncovers the development and propogation of these deadly compounds\, from their Nazi invention to their recent use by assassins in Salisbury\, England. \nDan Kaszeta has decades of experience in protecting against chemical and biological weapons\, and has held positions in the US Army\, the White House Military Office\, the US Secret Service and private industry. \nThe event is free but donations are encouraged. Learn more.
URL:https://globalbiodefense.com/event/toxic-a-history-of-nerve-agents/
LOCATION:
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201130T033000
DTEND;TZID=America/New_York:20201130T070000
DTSTAMP:20201101T174433Z
CREATED:20201101T174433Z
LAST-MODIFIED:20201101T174433Z
UID:47768-1606707000-1606719600@globalbiodefense.com
SUMMARY:Biological Weapons Convention: Orientation Workshop
DESCRIPTION:In preparation for the Biological Weapons Convention (BWC) 2020 Meeting of Experts in December 2020\, UNIDIR is hosting a brief BWC Orientation course for national delegates. The event will provide a basic introduction to the BWC and some of the key issues facing the Convention. It will also serve as opportunity for delegates to informally ask experts in the field any questions they may have related to the BWC. \nThe event will comprise of several short segments covering topics including international cooperation\, science and technology\, and transparency and compliance. UNIDIR will moderate the event. Confirmed speakers include: \n\nRichard Lennane\nZalini Binti Yunus\nYasemin Balci.\n\nLearn more: http://bit.ly/unidir-bwc-orientation
URL:https://globalbiodefense.com/event/biological-weapons-convention-orientation-workshop/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201201
DTEND;VALUE=DATE:20201203
DTSTAMP:20201127T195218Z
CREATED:20201127T195203Z
LAST-MODIFIED:20201127T195218Z
UID:48069-1606780800-1606953599@globalbiodefense.com
SUMMARY:Security of America’s Medical Product Supply Chain - Public Workshop
DESCRIPTION:The National Academies’ Committee on Security of America’s Medical Product Supply Chain will host its second meeting and a public workshop from December 1-3\, 2020. \nThe public workshop will be held on December 1 (12:00pm to 3:30pm) and December 2 (11:30am to 3:30pm). \nObjectives for the public workshop include the following: \n\nConsider on-the-ground perspectives from end users of the medical supply chain (e.g.\, patients\, clinicians\, health systems) when it comes to:\n\nwhat makes a medical product critical/essential\noutcome measures that matter to end users\napproaches to mitigate the impact of failures in the medical supply chain\n\n\nExamine current lists of “critical/essential” medical products with attention to how these lists were formulated and how they are used to inform decisions;\nDiscuss key considerations for the formulation of a unified list of critical medical products;\nConsider tactical approaches for improving supply chain resiliency.\n\nBackground\nIn response to the CARES Act\, the National Academies of Sciences\, Engineering\, and Medicine will establish an ad hoc committee to conduct a study to examine the security of the United States medical product supply chain. The committee will assess and evaluate the dependence of the United States on critical drugs and devices that are sourced or manufactured outside of the United States and provide recommendations to improve the resiliency of the medical supply chain. \nThe committee will: \n1) assess and evaluate the dependence of the United States\, including the private commercial sector\, States\, and the Federal Government\, on critical drugs and devices that are sourced or manufactured outside of the United States\, which may include an analysis of: \n\nthe supply chain of critical drugs and devices of greatest priority to providing health care;\nany potential public health security or national security risks associated with reliance on critical drugs and devices sourced or manufactured outside of the United States\, which may include responses to previous or existing shortages or public health emergencies\, such as infectious disease outbreaks\, bioterror attacks\, and other public health threats;\nany existing supply chain information gaps\, as applicable; and\npotential economic impact and other considerations associated with increased domestic manufacturing; and\n\n2) provide recommendations to improve the resiliency of the supply chain for critical drugs and devices and to address any supply vulnerabilities or potential disruptions of such products that would significantly affect or pose a threat to public health security or national security\, as appropriate\, which may include strategies to: \n\npromote supply chain redundancy and contingency planning;\nencourage domestic manufacturing\, including consideration of economic impacts\, if any;\nimprove supply chain information gaps;\nimprove planning considerations for medical product supply chain capacity during public health emergencies; and\npromote the accessibility of such drugs and devices.
URL:https://globalbiodefense.com/event/security-of-americas-medical-product-supply-chain-public-workshop/
LOCATION:
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201201T170000
DTEND;TZID=America/New_York:20201201T180000
DTSTAMP:20201127T194745Z
CREATED:20201127T194745Z
LAST-MODIFIED:20201127T194745Z
UID:48067-1606842000-1606845600@globalbiodefense.com
SUMMARY:Assessment of the SBIR and STTR Programs at NIH - Meeting 8
DESCRIPTION:The Eighth Meeting of the Committee on the Assessment of the SBIR and STTR Programs at the National Institutes of Health (NIH) will be held virtually on December 1\, 2020. \nWhat is the effectiveness of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH)? An ad hoc committee will conduct a study of the economic and healthcare benefits of the SBIR and STTR programs at NIH and the effectiveness of the enabling strategies NIH has employed to enhance the programs. \nMeeting will be held via Zoom. This meeting will be open in its entirety. \nPlease write to step@nas.edu to attend. \nBackground\nIn response to a Congressional mandate\, an ad hoc committee will conduct a study of the economic and healthcare benefits of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH) and the effectiveness of the enabling strategies NIH has employed to enhance the programs. The committee will draw on published research; existing\, available data; and case studies\, and convene a series of meetings. Specifically and to the extent that data are available\, the committee will examine: \nSBIR effectiveness: Leveraging existing NIH evaluation strategies and data that are made available to the committee\, case studies\, and other available data\, the committee will examine whether the NIH SBIR Program is fulfilling the requirements of the enabling legislation; and study the impact and effectiveness of the enabling strategies NIH has employed to enhance the program\, including\, but not limited to\, technical and business assistance programs and the Phase IIB program. \nSTTR effectiveness: Leveraging existing NIH evaluation strategies and data that are made available\, the committee will study how the NIH STTR Program\, including the strategies designed to enable academic entrepreneurship and innovation\, has fulfilled the requirements of the enabling legislation\, including: \n\nA review of the collaborations created between small businesses and research institutions\, including an evaluation of the effectiveness of the program in stimulating new collaborations and any obstacles that may prevent or inhibit the creation of such collaborations.\nAn evaluation of the effectiveness of the program at transferring federally funded technology and capabilities toward commercialization.\nAn examination of the non-economic impacts to businesses including measures of demographics\, participation of underrepresented groups\, and knowledge of the technical and business requirements of life science sector commercialization.\nAn analysis of whether STTR funds could be employed more effectively by the NIH STTR program to achieve the goals of the enabling legislation.
URL:https://globalbiodefense.com/event/assessment-of-the-sbir-and-sttr-programs-at-nih-meeting-8/
LOCATION:
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201203T110000
DTEND;TZID=America/New_York:20201203T143000
DTSTAMP:20201127T210413Z
CREATED:20201127T210413Z
LAST-MODIFIED:20201127T210413Z
UID:48071-1606993200-1607005800@globalbiodefense.com
SUMMARY:Lessons Learned in Health Professions Education from the COVID-19 Pandemic
DESCRIPTION:A planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and conduct a 1-day public workshop on Dec. 3\, 2020 to explore lessons learned in grand challenges facing health professions education (HPE) stemming from the COVID-19 pandemic and how those positive and negative experiences might inform development of sustainable improvements in the value\, effectiveness\, and impact of HPE. The planning committee will bring together educators\, students\, administrators\, and health professionals to share ideas\, stories\, and data in an effort to discuss the future of HPE by learning from past experiences. Invited presentations and discussions will involve global audiences in topics such as: \n\nExamples and evaluation of online education;\nInnovations in interprofessional education and learning opportunities within the social determinants of health and mental health;\nImpacts on pre-clinical and clinical education;\nRegulatory and accreditation changes affecting HPE; and\nStress and workload on students and faculty.\n\nRegister here.
URL:https://globalbiodefense.com/event/lessons-learned-in-health-professions-education-from-the-covid-19-pandemic/
LOCATION:
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
END:VCALENDAR